|
1
|
Canna SW and Marsh RA: Pediatric
hemophagocytic lymphohistiocytosis. Blood. 135:1332–1343. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu P, Pan X, Chen C, Niu T, Shuai X, Wang
J, Chen X, Liu J, Guo Y, Xie L, et al: Nivolumab treatment of
relapsed/refractory Epstein-Barr virus-associated hemophagocytic
lymphohistiocytosis in adults. Blood. 135:826–833. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ishii E, Ohga S, Imashuku S, Yasukawa M,
Tsuda H, Miura I, Yamamoto K, Horiuchi H, Takada K, Ohshima K, et
al: Nationwide survey of hemophagocytic lymphohistiocytosis in
Japan. Int J Hematol. 86:58–65. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yao S, Jin Z, He L, Zhang R, Liu M, Hua Z,
Wang Z and Wang Y: Clinical features and prognostic risk prediction
of non-Hodgkin lymphoma-associated hemophagocytic syndrome. Front
Onco. 11:7880562021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lin CH, Shih YH, Chen TC, Chou CW, Hsu CY
and Teng CJ: A decade of lymphoma-associated hemophagocytic
lymphohistiocytosis: Does the outcome improve? J Clin Med.
10:51142021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bigenwald C, Fardet L, Coppo P, Meignin V,
Lazure T, Fabiani B, Kohn M, Oksenhendler E, Boutboul D, Uzzan M,
et al: A comprehensive analysis of Lymphoma-associated
haemophagocytic syndrome in a large French multicentre cohort
detects some clues to improve prognosis. Br J Haematol. 183:68–75.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Giza A, Gałązka K, Jońca M, Raźny M,
Zimowska-Curyło D, Wilk M, Goldman-Mazur S, Piątkowska-Jakubas B
and Sacha T: Subcutaneous panniculitis-like T-cell lymphoma (SPTCL)
with probable mesentery involvement with associated hemophagocytic
syndrome (HPS)-how to treat it? J Dermatolog Trea. 33:2674–2676.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lehmberg K, Nichols KE, Henter JI,
Girschikofsky M, Greenwood T, Jordan M, Kumar A, Minkov M, La Rosée
P and Weitzman S; Study Group on Hemophagocytic Lymphohistiocytosis
Subtypes of the Histiocyte Society, : Consensus recommendations for
the diagnosis and management of hemophagocytic lymphohistiocytosis
associated with malignancies. Haematologic. 100:997–1004.
2015.PubMed/NCBI
|
|
9
|
Tong H, Ren Y, Liu H, Xiao F, Mai W, Meng
H, Qian W, Huang J, Mao L, Tong Y, et al: Clinical characteristics
of T-cell lymphoma associated with hemophagocytic syndrome:
Comparison of T-cell lymphoma with and without hemophagocytic
syndrome. Leuk Lymphoma. 49:81–87. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Song Y, Yin Q, Wang J and Wang Z:
Autologous hematopoietic stem cell transplantation for patients
with lymphoma-associated hemophagocytic lymphohistiocytosis. Cell
Transplant. 30:96368972110570772021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Henter JL, Samuelsson-Horne AC, Aricò M,
Egeler RM, Elinder G, Filipovich AH, Gadner H, Imashuku S, Komp D,
Ladisch S, et al: Treatment of hemophagocytic lymphohistiocytosis
with HLH-94 immunochemotherapy and bone marrow transplantation.
Blood. 100:2367–2373. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Birndt S, Schenk T, Heinevetter B,
Brunkhorst FM, Maschmeyer G, Rothmann F, Weber T, Müller M, Panse
J, Penack O, et al: Hemophagocytic lymphohistiocytosis in adults:
Collaborative analysis of 137 cases of a nationwide German
registry. J Cancer Res Clin Onco. 146:1065–1077. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chang Y, Cui M, Fu X, Han L, Zhang L, Li
L, Li X, Sun Z, Wu J, Zhang X, et al: Lymphoma associated
hemophagocytic syndrome: A single-center retrospective study. Oncol
Lett. 16:1275–1284. 2018.PubMed/NCBI
|
|
14
|
Liu YZ, Bi LQ, Chang GL, Guo Y and Sun S:
Clinical characteristics of extranodal NK/T-cell
lymphoma-associated hemophagocytic lymphohistiocytosis. Cancer
Manag Res. 11:997–1002. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Daver N, McClain K, Allen CE, Parikh SA,
Otrock Z, Rojas-Hernandez C, Blechacz B, Wang S, Minkov M, Jordan
MB, et al: A consensus review on malignancy-associated
hemophagocytic lymphohistiocytosis in adults. Cancer.
123:3229–3240. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ren Q, Chan KW, Huang H, Wang Z, Fang X,
Guo C, Li F, Zhang L, Yao Y, Chen Z, et al: Platelet-derived
alpha-granules are associated with inflammation in patients with
NK/T-cell lymphoma-associated hemophagocytic syndrome. Cytokine.
126:1548782020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Meng G, Wang Y, Wang J and Wang Z: The DEP
regimen is superior to the HLH-1994 regimen as first-line therapy
for lymphoma-associated haemophagocytic lymphohistiocytosis. Leuk
Lymphoma. 62:854–860. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Henter JI, Horne A, Aricó M, Egeler RM,
Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski
J and Janka G: HLH-2004: Diagnostic and therapeutic guidelines for
hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer.
48:124–131. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jin Z, Wang Y, Wei N and Wang Z: Hodgkin
lymphoma-associated hemophagocytic lymphohistiocytosis-a dangerous
disease. Ann Hematol. 99:1575–1581. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pasvolsky O, Zoref-Lorenz A, Abadi U,
Geiger KR, Hayman L, Vaxman I, Raanani P and Leader A:
Hemophagocytic lymphohistiocytosis as a harbinger of aggressive
lymphoma: A case series. Int J Hematol. 109:553–562. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li W, Zhong Y, Shuang Y, Huang H, Huang Y,
Yu L and Huang X: High concentration of miR-133 is a useful marker
for the diagnosis of lymphoma-associated hemophagocytic syndrome.
Cancer Biomark. 20:159–164. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yuan S, Wang Y, Luo H, Jiang Z, Qiao B,
Jiang Y, Hu Y, Cheng Y, Chen X, Gong W, et al: Serum soluble VSIG4
as a surrogate marker for the diagnosis of lymphoma-associated
hemophagocytic lymphohistiocytosis. Br J Haematol. 189:72–83. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bin Q, Gao JH and Luo JM: Prognostic
factors of early outcome in pediatric hemophagocytic
lymphohistiocytosis: An analysis of 116 cases. Ann Hematol.
95:1411–1418. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
George MR: Hemophagocytic
lymphohistiocytosis: Review of etiologies and management. J Blood
Med. 5:69–86. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Prokesch BC, Nagalla S, Ezzati F, Tujios
SR, Dominguez A, Chen W, Kershaw C, Patel P, de la Flor C, Foster
J, et al: What's in a name? The heterogeneous clinical spectrum and
prognostic factors in a cohort of adults with hemophagocytic
lymphohistiocytosis. Transfus Apher Sci. 57:779–784. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li J, Wang Q, Zheng W, Ma J, Zhang W, Wang
W and Tian X: Hemophagocytic lymphohistiocytosis: Clinical analysis
of 103 adult patients. Medicine (Baltimore). 93:100–105. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jin Z, Wang Y, Wang J, Wu L, Pei R, Lai W
and Wang Z: Multivariate analysis of prognosis for patients with
natural killer/T cell lymphoma-associated hemophagocytic
lymphohistiocytosis. Hematology. 23:228–234. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bhatt NS, Oshrine B and An Talano J:
Hemophagocytic lymphohistiocytosis in adults. Leuk Lymphoma.
60:19–28. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee DE, Martinez-Escala ME, Serrano LM,
Zhou XA, Kaplan JB, Pro B, Choi J and Guitart J: Hemophagocytic
lymphohistiocytosis in cutaneous T-cell lymphoma. JAMA Dermatol.
154:828–831. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Takahashi N, Chubachi A, Miura I, Nakamura
S and Miura AB: Lymphoma-associated hemophagocytic syndrome in
Japan. Rinsho Ketsueki. 40:542–549. 1999.(In Japanese). PubMed/NCBI
|
|
31
|
Malkan UY, Albayrak M, Yildiz M, Maral S,
Afacan Ozturk HB and Comert P: A rare case of diffuse large B-cell
lymphoma-associated hemophagocytic lymphohistiocytosis. J Oncol
Pharm Pract. 27:250–252. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Han L, Li L, Wu J, Li X, Zhang L, Wang X,
Fu X, Ma W, Sun Z, Zhang X, et al: Clinical features and treatment
of natural killer/T cell lymphoma associated with hemophagocytic
syndrome: Comparison with other T cell lymphoma associated with
hemophagocytic syndrome. Leuk Lymphoma. 55:2048–2055. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Signoff JK, Fitzgerald JC, Teachey DT,
Balamuth F and Weiss SL: Hypofibrinogenemia is associated with poor
outcome and secondary hemophagocytic lymphohistiocytosis/macrophage
activation syndrome in pediatric severe sepsis. Pediatr Crit Care
Med. 19:397–405. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li N, Zhang L, Liu J, Zhang J, Weng HW,
Zhuo HY and Zou LQ: A clinical study of 21 patients with
hemophagocytic syndrome in 295 cases diagnosed with nasal type,
extranodal nature killer/T cell lymphoma. Cancer Biol Ther.
18:252–256. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jiang T, Ding X and Lu W: The prognostic
significance of beta2 microglobulin in patients with hemophagocytic
lymphohistiocytosis. Dis Markers. 2016:15239592016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pan H, Huo Y and Sun L: Comparison between
clinical features and prognosis of malignancy- and
non-malignancy-associated pediatric hemophagocytic
lymphohistiocytosis. BMC Pediatr. 19:4682019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Valade S, Mariotte E and Azoulay E:
Coagulation disorders in hemophagocytic
lymphohistiocytosis/macrophage activation syndrome. Crit Care Clin.
36:415–426. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jia J, Song Y, Lin N, Liu W, Ping L, Zheng
W, Wang X, Xie Y, Tu M, Zhang C, et al: Clinical features and
survival of extranodal natural killer/T cell lymphoma with and
without hemophagocytic syndrome. Ann Hematol. 95:2023–2031. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Uni M, Yoshimi A, Maki H, Maeda D,
Nakazaki K, Nakamura F, Fukayama M and Kurokawa M: Successful
treatment with recombinant thrombomodulin for B-cell
lymphoma-associated hemophagocytic syndrome complicated by
disseminated intravascular coagulation. Int J Clin Exp Pathol.
6:1190–1194. 2013.PubMed/NCBI
|
